Moderna To Receive $176 Million From United States Government To Develop mRNA Jab For Bird Flu

From 100PercentFedUp - READ ORIGINAL

Some media, including videos, may only be available to view at the original.  

Share this:

The United States government will give COVID-19 jab manufacturer Moderna $176 million to develop an mRNA shot for bird flu.

“Moderna already has a bird flu vaccine in very early-stage testing that uses the same mRNA technology that allowed rapid development and rollout of vaccines to protect against COVID-19,” the Associated Press reports.

After the catastrophic damage from the mRNA COVID-19 shots, the U.S. government wants to roll out the same type of injections for another scamdemic.

“The award also enables rapid development of mRNA vaccine targeted to various influenza virus subtypes, or strains, with pandemic potential. Development and manufacturing can pivot quickly, if needed to address other emerging infectious diseases, HHS said,” the McCullough Foundation stated.

From the Associated Press:

The new funds from the U.S. Department of Health and Human Services include continued development of the vaccine, including a late-stage trial next year if those early study results are positive.

But the project can be quickly redirected to target another form of influenza if a different threat than the H5N1 form of bird flu emerges, HHS officials stressed.

The award was made through the Biomedical Advanced Research and Development Authority, or BARDA, a program that focuses on medical treatments for potential pandemics.

The H5N1 virus was detected earlier this year in dairy cows and has spread to more than 135 herds in 12 states and infected three people to date, all with mild cases. Federal health officials stress that the risk to the wider population remains low.

The bird flu fearmongering campaign is in full force despite the COVID-19 debacle that woke up many people worldwide.

Do the same players expect the same playbook will work with bird flu?

Hopefully, humanity has learned its lesson and won’t get fooled again.

Today, @BARDA announced plans to provide $176 million in funding to @moderna_tx for the development of pandemic influenza mRNA-based vaccines. The new award will help speed the development of additional pandemic influenza vaccine response capacity,” HHS ASPR wrote.

Per Axios:

Moderna has a candidate bird flu vaccine in phase one trials and data about its effectiveness should be available coming weeks, Health and Human Services Assistant Secretary for Preparedness and Response Dawn O’Connell said during a call Tuesday with reporters.

If the vaccine candidate is determined safe and effective, a phase three trial is expected to begin in 2025, O’Connell said.

The contract between BARDA and Moderna has an option to accelerate development “if it looks like we’re starting to see some pressure regarding what is happening with the dairy cows and starting to get extraordinarily concerned about additional human cases, severity of human cases, human-to human-transmission,” O’Connell said.

The first doses of an existing vaccine against bird flu that uses a traditional vaccine platform are expected to be complete later this month. The federal government contracted CSL Seqirus to produce 4.8 million doses of the vaccine.

Officials confirmed they are considering making the first doses of the traditional vaccine available to farm workers who are at higher risk of exposure to the virus but the finished doses would need to undergo final FDA and CDC approvals.

Notify of

Inline Feedbacks
View all comments